1.
Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronickidney disease-a systematic review and meta-analysis. PloS one2016; 11: e0158765..
2.
London GM, Safar ME, Pannier B: Aortic aging in ESRD:structural, hemodynamic, and mortality implications. J Am SocNephrol 2016; 27: 1837-46.
3.
Mathew RO, Bangalore S, Lavelle MP, et al. Diagnosis andmanagement of atherosclerotic cardiovascular disease in chronickidney disease: a review. Kidney Int 2017; 91: 797-807.
4.
Saran R, Li Y, Robinson B, et al. US Renal Data System 2015Annual Data Report: Epidemiology of Kidney Disease in theUnited States. Am J Kidney Dis 2016; 67: Svii S1-305.
5.
Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG.Aortic stiffness is independently associated with rate of renalfunction decline in chronic kidney disease stages 3 and 4.Hypertension 2010; 55: 1110-5.
6.
Taal MW: Arterial stiffness in chronic kidney disease: an update.Current Opinion in Nephrology and Hypertension 2014; 23: 169-73.
7.
Baykara M, Demirel A, Yavuzatmaca I, Bilgen M. Response ofarterial stiffness four weeks after terminating short-term aerobicexercise training in a sedentary lifestyle. J Ultrasound Med 2017;36: 353-9.
8.
Bansal N: Evolution of cardiovascular disease during thetransition to end-stage renal disease. In: Seminars in Nephrology, Elsevier 2017: 120-31.
9.
Dalrymple LS, Katz R, Kestenbaum B, et al. Chronic kidneydisease and the risk of end-stage renal disease versus death. JGeneral Int Med 2011; 26: 379-385.
10.
Matsushita K, Van der Velde M, Astor B, et al. Chronic KidneyDisease Prognosis Consortium: Association of estimatedglomerular filtration rate and albuminuria with all-causeand cardiovascular mortality in general population cohorts:a collaborative meta-analysis. Lancet 2010; 375: 2073-81.
11.
Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events inpeople with chronic kidney disease compared with those withdiabetes: a population-level cohort study. Lancet 2012; 380: 807-14.
12.
Yerram P, Karuparthi PR, Hesemann L, Horst J, Whaley-ConnellA. Chronic kidney disease and cardiovascular risk. J Am SocHypertens 2007; 1: 178-84.
13.
Khamdaeng T, Luo J, Vappou J, Terdtoon P, Konofagou E. Arterialstiffness identification of the human carotid artery using thestress-strain relationship in vivo. Ultrasonics 2012; 52: 402-11.
14.
Townsend RR: Arterial stiffness in CKD: a review. Am J KidneyDis 2019; 73: 240-7.
15.
Alani H, Tamimi A, Tamimi N. Cardiovascular co-morbidity inchronic kidney disease: Current knowledge and future researchneeds. World J Nephrol 2014; 3: 156-68.
16.
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction ofcardiovascular events and all-cause mortality with arterialstiffness: a systematic review and meta-analysis. J Am Coll Cardiol2010; 55: 1318-27.
17.
Salvi P, Parati G. Arterial stiffness and renal function—a complexrelationship. Nat Rev Nephrol 2015; 11: 11-3.
18.
Mitchell GF. Arterial stiffness and hypertension. Hypertension2014; 64: 13-8.
19.
Vlachopoulos C, Xaplanteris P, Aboyans V, et al. The role ofvascular biomarkers for primary and secondary prevention. Aposition paper from the European Society of Cardiology WorkingGroup on peripheral circulation: Endorsed by the Associationfor Research into Arterial Structure and Physiology (ARTERY)Society. Atherosclerosis 2015; 241: 507-32.
20.
Zanoli L, Empana J-P, Perier M-C, et al. Increased carotid stiffnessand remodelling at early stages of chronic kidney disease. JHypertens 2019; 37: 1176-82.
21.
Nemcsik J, Kiss I, Tislér A. Arterial stiffness, vascular calcificationand bone metabolism in chronic kidney disease. World J Nephrol2012; 1: 25.
22.
McIntyre NJ, Fluck RJ, McIntyre CW, Fakis A, Taal MW.Determinants of arterial stiffness in chronic kidney disease stage3. PLoS One 2013; 8: e55444.
23.
Verhave JC, Fesler P, Du Cailar G, Ribstein J, Safar ME, MimranA. Elevated pulse pressure is associated with low renal function inelderly patients with isolated systolic hypertension. Hypertension2005; 45: 586-91.
24.
Cesana F, Giannattasio C, Nava S, et al. Impact of blood glucosevariability on carotid artery intima media thickness anddistensibility in type 1 diabetes mellitus. Blood Pressure 2013; 22:355-61.
25.
Baykara S, Bozdağ PG, Baykara M, Namlı MN. Evaluation ofarterial stiffness in patients with schizophrenia. J Clin Neurosci2020; 79: 149-53.
26.
Sarıca MA, İmam S. Cilostazol decreased carotid arterial stiffnessand increased vertebral arterial flows in patient with peripheralarterial. Ann Vasc Med Res 2016; 3: 1034.